Memorial Sloan Kettering Cancer Center: Small Cell Lung Carcinoma trials

The registry lists 12 Small Cell Lung Carcinoma studies with Memorial Sloan Kettering Cancer Center as lead sponsor. 5 are open to participants now and 2 have results posted.

Phase 1 7Phase 2 5No phase 2(a study in two phases counts in both)

Studies

Open to participants first, then studies with results posted, then the rest; newest registration first within each.

• A Study of Armored CAR T Cells in People With CancerRecruitingNCT07783477Phase 1
• A Study of Hospital-at-Home for People Receiving TarlatamabRecruitingNCT06957314Not applicable
• A Study of Valemetostat in Combination With Atezolizumab in People With Lung CancerRecruitingNCT06807632Phase 1
• A Study of Stereotactic Radiosurgery (SRS) for People With Lung Cancer That Has Spread to the BrainRecruitingNCT05419076Phase 2
• PET/CT Imaging of Small Cell Lung Cancer Using 89Zr-DFO-SC16.56RecruitingNCT04199741Phase 1/2
• DS-3201b and Irinotecan for Patients With Recurrent Small Cell Lung CancerTerminatedNCT03879798Phase 1/2Results posted
• Temozolomide for Relapsed Sensitive or Refractory Small Cell Lung CancerCompletedNCT00740636Phase 2Results posted
• A Study of Olaparib and Low Dose Radiotherapy for Small Cell Lung CancerCompletedNCT03532880Phase 1
• Combination of the Hedgehog Inhibitor, LDE225, With Etoposide and Cisplatin in the First-Line Treatment of Patients With Extensive Stage Small Cell Lung Cancer (ES-SCLC)CompletedNCT01579929Phase 1
• An Analysis of the Response of Human Tumor Microvascular Endothelium to Ionizing RadiationCompletedNCT00132704
• Imatinib Mesylate and Chemotherapy in Treating Patients With Extensive-Stage Small Cell Lung CancerCompletedNCT00045604Phase 1
• Vaccine Therapy Plus QS21 in Treating Patients With Small Cell Lung Cancer That Has Responded to Initial TherapyCompletedNCT00004249Phase 2